Daniela Zantomio

401 total citations
17 papers, 239 citations indexed

About

Daniela Zantomio is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Daniela Zantomio has authored 17 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in Daniela Zantomio's work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Daniela Zantomio is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Daniela Zantomio collaborates with scholars based in Australia, United Kingdom and United States. Daniela Zantomio's co-authors include Christos Pantelis, Efstratios Skafidas, Gursharan Chana, Andrew Grigg, Ian Everall, Rosemary A. Ayton, Jeff Szer, Lachlan MacGregor, Liliana Laskaris and Renée Testa and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Daniela Zantomio

15 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Zantomio Australia 7 66 57 41 40 30 17 239
Hiroko Shigemi Japan 11 44 0.7× 69 1.2× 46 1.1× 104 2.6× 53 1.8× 29 355
Axel Lebas France 9 30 0.5× 50 0.9× 44 1.1× 20 0.5× 16 0.5× 13 303
Joaquín A. Peña Venezuela 9 19 0.3× 33 0.6× 14 0.3× 62 1.6× 26 0.9× 28 370
Sarah Morse United States 7 41 0.6× 27 0.5× 38 0.9× 114 2.9× 8 0.3× 15 261
Mélanie Steffens Germany 11 35 0.5× 85 1.5× 17 0.4× 84 2.1× 33 1.1× 20 355
E. Maida Austria 12 21 0.3× 34 0.6× 21 0.5× 57 1.4× 67 2.2× 34 458
Paulo Ribeiro Nóbrega Brazil 12 11 0.2× 36 0.6× 53 1.3× 85 2.1× 20 0.7× 62 414
Jason S. Gill United States 7 82 1.2× 34 0.6× 28 0.7× 42 1.1× 5 0.2× 10 355
Jens Ehrhardt Germany 11 16 0.2× 67 1.2× 9 0.2× 32 0.8× 15 0.5× 24 408
Ružica Kravljanac Serbia 11 41 0.6× 21 0.4× 66 1.6× 52 1.3× 14 0.5× 32 408

Countries citing papers authored by Daniela Zantomio

Since Specialization
Citations

This map shows the geographic impact of Daniela Zantomio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Zantomio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Zantomio more than expected).

Fields of papers citing papers by Daniela Zantomio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Zantomio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Zantomio. The network helps show where Daniela Zantomio may publish in the future.

Co-authorship network of co-authors of Daniela Zantomio

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Zantomio. A scholar is included among the top collaborators of Daniela Zantomio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Zantomio. Daniela Zantomio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brewster, Jessica, Christopher Hogan, John Kanellis, et al.. (2025). Human leukocyte antigen sensitization from red cell transfusions: Rate and risk factors in renal and nonrenal patients requiring transfusion. American Journal of Transplantation. 26(2). 291–303.
3.
Jones, Robert M., Graham Starkey, Marcos V. Perini, et al.. (2021). The use of organ donor blood in liver transplantation. Clinical Transplantation. 35(9). e14419–e14419. 1 indexed citations
4.
Chana, Gursharan, et al.. (2020). Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics. Clinical Infectious Diseases. 73(9). e3047–e3052. 1 indexed citations
5.
Pantelis, Christos, Mahesh Jayaram, Anthony J. Hannan, et al.. (2020). Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19. Australian & New Zealand Journal of Psychiatry. 55(8). 750–762. 30 indexed citations
6.
Kenealy, Melita, Mark Hertzberg, Kerry Taylor, et al.. (2018). Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia. Haematologica. 104(4). 700–709. 13 indexed citations
7.
Schwarer, Anthony P., Jason Butler, Kathryn Jackson, et al.. (2018). A Comparison of High‐Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2(6). e158–e158. 2 indexed citations
8.
Chua, Chong Chyn, et al.. (2018). Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis. Pathology. 50(6). 671–674. 1 indexed citations
9.
Skafidas, Efstratios, Mirella Dottori, Daniela Zantomio, et al.. (2017). No preliminary evidence of differences in astrocyte density within the white matter of the dorsolateral prefrontal cortex in autism. Molecular Autism. 8(1). 64–64. 13 indexed citations
10.
Abeyrathne, Chathurika D., Duc Huynh, Babak Nasr, et al.. (2016). Lab on a chip sensor for rapid detection and antibiotic resistance determination of Staphylococcus aureus. The Analyst. 141(6). 1922–1929. 28 indexed citations
12.
Zantomio, Daniela, Gursharan Chana, Liliana Laskaris, et al.. (2015). Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD. Neuroscience & Biobehavioral Reviews. 52. 172–177. 31 indexed citations
13.
Chana, Gursharan, Liliana Laskaris, Christos Pantelis, et al.. (2015). Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications. Brain Behavior and Immunity. 49. 197–205. 43 indexed citations
14.
Lasica, Masa & Daniela Zantomio. (2015). Severe intravenous immunoglobulin‐induced hemolysis with pigment nephropathy managed with red cell exchange. Journal of Clinical Apheresis. 31(5). 464–466. 2 indexed citations
15.
Kenealy, Melita, William G. Stetler‐Stevenson, Richard Eek, et al.. (2015). 13 THE ADDITION OF LENALIDOMIDE TO AZACITIDINE ACHIEVES HIGHER RESPONSES BUT NO IMPROVEMENT IN TWELVE MONTH CLINICAL BENEFIT OR PFS; MAIN ANALYSIS AUSTRALIAN ALLG MDS4 TRIAL. Leukemia Research. 39. S5–S5. 5 indexed citations
16.
Kenealy, Melita, J.F. Seymour, William G. Stetler‐Stevenson, et al.. (2013). P-272 The combination of azacitidine and lenalidomide is deliverable without unexpected toxicity; interim safety results of the ALLG MDS4 randomised trial. Leukemia Research. 37. S145–S145. 1 indexed citations
17.
Zantomio, Daniela, et al.. (2006). Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplantation. 38(8). 567–572. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026